Screener
Design Therapeutics, Inc. DSGN Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Reconciliation of net loss to net cash used in operating activities: | ||
| Depreciation | 157 | 159 |
| Stock-based compensation | 3,924 | 3,539 |
| Amortization of premiums on investment securities, net | (147) | (1,060) |
| Non-cash lease expense | 69 | (4) |
| Change in operating assets and liabilities: | ||
| Prepaid expense and other assets | (287) | (1,407) |
| Accounts payable and other liabilities | (2,511) | (301) |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Design Therapeutics, Inc. (DSGN) reported accretion (amortization) of discounts and premiums, investments of $147K in Q1 2026.
- How has Design Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Design Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 86.1% year-over-year, from $1.06M to $147K.
- What is the long-term trend for Design Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2022 to 2025), Design Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 32.6% compound annual growth rate (CAGR), from $1.4M to $3.25M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This metric represents the non-cash adjustment to net income resulting from the amortization of premiums or the accretion of discounts on debt or investment securities held by the company. It reflects the gradual adjustment of the carrying value of these assets toward their face value over time. Investors monitor this to understand how non-cash interest-related adjustments impact the company's reported operating cash flow.
Ask your AI about Design Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude